122 related articles for article (PubMed ID: 27017766)
1. [Anesthetic Management for Lobectomy in a Patient with Pulmonary Arterial Hypertension].
Imajo Y; Komasawa N; Kusaka Y; Kido H; Minami T
Masui; 2016 Feb; 65(2):139-41. PubMed ID: 27017766
[TBL] [Abstract][Full Text] [Related]
2. [Anesthetic Management of Right Lower Lobectomy in a Patient with Marfan Syndrome].
Deguchi S; Komasawa N; Matsunami S; Kusaka Y; Ohchi F; Minami T
Masui; 2015 May; 64(5):530-3. PubMed ID: 26422961
[TBL] [Abstract][Full Text] [Related]
3. [Treatment problems of idiopathic arterial pulmonary hypertension--case report].
Gradzik K; Kociubińska M; Wójcik M; Czarnota T; Mazur-Stazka E; Wysokiński A
Pol Merkur Lekarski; 2014 Jun; 36(216):397-9. PubMed ID: 25095640
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic stability after transitioning between endothelin receptor antagonists in patients with pulmonary arterial hypertension.
Fox B; Langleben D; Hirsch AM; Schlesinger RD; Eisenberg MJ; Joyal D; Blenkhorn F; Lesenko L
Can J Cardiol; 2013 Jun; 29(6):672-7. PubMed ID: 22819360
[TBL] [Abstract][Full Text] [Related]
5. Cardiorespiratory changes in patients undergoing pulmonary resection using different anesthetic management techniques.
Boldt J; Müller M; Uphus D; Padberg W; Hempelmann G
J Cardiothorac Vasc Anesth; 1996 Dec; 10(7):854-9. PubMed ID: 8969390
[TBL] [Abstract][Full Text] [Related]
6. [Anesthesia for partial pulmonary resection in a postpneumonectomy patient].
Kishi Y; Taniguchi H; Nakagawa M; Kita T; Mammoto T; Kanbara N; Sakai T
Masui; 2002 Mar; 51(3):261-3. PubMed ID: 11925889
[TBL] [Abstract][Full Text] [Related]
7. [Anesthetic Management for Non-cardiac Surgery in a Patient with Severe Pulmonary Arterial Hypertension].
Ohno S; Niiyama Y; Murouchi T; Yamakage M
Masui; 2016 May; 65(5):526-9. PubMed ID: 27319099
[TBL] [Abstract][Full Text] [Related]
8. Ambrisentan and its role in the management of pulmonary arterial hypertension.
Macintyre IM; Dhaun N; Goddard J; Webb DJ
Drugs Today (Barc); 2008 Dec; 44(12):875-85. PubMed ID: 19198697
[TBL] [Abstract][Full Text] [Related]
9. Initial tadalafil and ambrisentan combination therapy in pulmonary arterial hypertension: cLinical and haemodYnamic long-term efficacy (ITALY study).
D'Alto M; Romeo E; Argiento P; Paciocco G; Prediletto R; Ghio S; Correale M; Lo Giudice F; Badagliacca R; Greco A; Vizza CD
J Cardiovasc Med (Hagerstown); 2018 Jan; 19(1):12-17. PubMed ID: 29215546
[TBL] [Abstract][Full Text] [Related]
10. [Long-term effects with ambrisentan monotherapy in patients with pulmonary arterial hypertension].
Wen L; Jiang X; An P; He J; Zheng L; Liu Q; Peng F; Xu X; Jing Z
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Jun; 42(6):469-73. PubMed ID: 25164219
[TBL] [Abstract][Full Text] [Related]
11. [Anesthetic management of concomitant off-pump coronary artery bypass grafting, pulmonary resection, and mastectomy].
Shibusawa M; Toraiwa S; Saitoh S
Masui; 2006 Feb; 55(2):212-4. PubMed ID: 16491903
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy evaluation of ambrisentan in pulmonary hypertension.
Vizza CD; Fedele F; Pezzuto B; Rubin LJ
Expert Opin Drug Saf; 2012 Nov; 11(6):1003-11. PubMed ID: 22861496
[TBL] [Abstract][Full Text] [Related]
13. [Effects of ambrisentan in treatment of pulmonary arterial hypertension: a pilot study with 15 patients].
He J; Wen L; Jiang R; Zhao QH; Wang L; Jiang X; Yan P; Bai L; Jing ZC
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Jun; 41(6):493-6. PubMed ID: 24113042
[TBL] [Abstract][Full Text] [Related]
14. Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension.
Galiè N; Barberà JA; Frost AE; Ghofrani HA; Hoeper MM; McLaughlin VV; Peacock AJ; Simonneau G; Vachiery JL; Grünig E; Oudiz RJ; Vonk-Noordegraaf A; White RJ; Blair C; Gillies H; Miller KL; Harris JH; Langley J; Rubin LJ;
N Engl J Med; 2015 Aug; 373(9):834-44. PubMed ID: 26308684
[TBL] [Abstract][Full Text] [Related]
15. Role of ambrisentan in the management of pulmonary hypertension.
Hrometz SL; Shields KM
Ann Pharmacother; 2008 Nov; 42(11):1653-9. PubMed ID: 18957622
[TBL] [Abstract][Full Text] [Related]
16. Monitored anesthesia care with dexmedetomidine of a patient with severe pulmonary arterial hypertension for inguinal hernioplasty.
Shinohara H; Hirota K; Sato M; Kakuyama M; Fukuda K
J Anesth; 2010 Aug; 24(4):611-3. PubMed ID: 20467877
[TBL] [Abstract][Full Text] [Related]
17. Ambrisentan (Letairis) for pulmonary arterial hypertension.
Med Lett Drugs Ther; 2007 Oct; 49(1272):87-8. PubMed ID: 17938611
[No Abstract] [Full Text] [Related]
18. Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.
Hassoun PM; Zamanian RT; Damico R; Lechtzin N; Khair R; Kolb TM; Tedford RJ; Hulme OL; Housten T; Pisanello C; Sato T; Pullins EH; Corona-Villalobos CP; Zimmerman SL; Gashouta MA; Minai OA; Torres F; Girgis RE; Chin K; Mathai SC
Am J Respir Crit Care Med; 2015 Nov; 192(9):1102-10. PubMed ID: 26360334
[TBL] [Abstract][Full Text] [Related]
19. A review of pulmonary arterial hypertension: role of ambrisentan.
Barst RJ
Vasc Health Risk Manag; 2007; 3(1):11-22. PubMed ID: 17583171
[TBL] [Abstract][Full Text] [Related]
20. Long-term pulmonary hemodynamic effects of ambrisentan in pulmonary arterial hypertension.
Klinger JR; Oudiz RJ; Spence R; Despain D; Dufton C
Am J Cardiol; 2011 Jul; 108(2):302-7. PubMed ID: 21545989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
